That's what a 'going concern' paragraph is for. And you're presuming Mazars USA is conducting an audit which costs in excess of $30,000. The prohibitive cost is why OTC clients typically choose a review or compilation. That provides a lower level of assurance to shareholders but it to saves ONCI (the client) a ton of money.
Market Data 
Markets 
AI
